• The 1960s epidemic of asthma deaths that affected young persons in England and Wales, as well as in other countries, was attributed to the effect of newly available pressurized aerosols containing sympathomimetic bronchodilators. The subsequent decision to ban the nonprescription sale of these agents in the United Kingdom represented a unique use of national and international mortality data. The application of such data for decisions about therapeutic agents has implications for the current rise of asthma deaths in New Zealand, for the recent United States regulatory action regarding the nonprescription sale of aerosolized bronchodilators, and for the appraisal of adverse reactions to other pharmaceutical substances. This article is concerned with the quality of the scientific evidence used to implicate bronchodilators in the 1960s epidemic, and also with the strengths and weaknesses of the ecologic studies on which the implication depended. After concluding that the causal link between asthma deaths and bronchodilators was not supported by satisfactory scientific evidence, we present new data and an alternative diagnostic-exchange hypothesis that may, in part, help explain the original association.
(Arch Intern Med 1987;147:543-549)
Esdaile JM, Feinstein AR, Horwitz RI. A Reappraisal of the United Kingdom Epidemic of Fatal AsthmaCan General Mortality Data Implicate a Therapeutic Agent?. Arch Intern Med. 1987;147(3):543–549. doi:10.1001/archinte.1987.00370030147029
Customize your JAMA Network experience by selecting one or more topics from the list below.